Fingerprint
Dive into the research topics of 'Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?
Axel S. Merseburger, Peter Hammerer, Francois Rozet, Thierry Roumeguère, Orazio Caffo, Fernando Calais da Silva, Antonio Alcaraz*
*Corresponding author for this work
24
Citations
(Scopus)